Literature DB >> 613539

The role of testing in coronary artery disease.

K Cohn.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 613539      PMCID: PMC1237515     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  9 in total

1.  Interpretation and limitations in stress testing.

Authors:  K Cohn
Journal:  Adv Cardiol       Date:  1976

2.  Marked depth of ST-segment depression during treadmill exercise testing; indicator of severe coronary artery disease.

Authors:  S Goldman; S Tselos; K Cohn
Journal:  Chest       Date:  1976-06       Impact factor: 9.410

3.  Whither the ST segment during exercise.

Authors:  D R Redwood; J S Borer; S E Epstein
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

4.  Epidemiologic study of asymptomatic men screened by maximal treadmill testing for latent coronary artery disease.

Authors:  V F Froelicher; M M Thomas; C Pillow; M C Lancaster
Journal:  Am J Cardiol       Date:  1974-12       Impact factor: 2.778

5.  Uses and limitations of stress testing in the evaluation of ischemic heart disease.

Authors:  D R Redwood; S E Epstein
Journal:  Circulation       Date:  1972-12       Impact factor: 29.690

6.  Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests.

Authors:  P Rochmis; H Blackburn
Journal:  JAMA       Date:  1971-08-23       Impact factor: 56.272

7.  Postexercise electrocardiogram in arteriosclerotic heart disease. Its value in diagnosis and prognosis.

Authors:  G P Robb; H H Marks
Journal:  JAMA       Date:  1967-06-12       Impact factor: 56.272

8.  Treadmill stress tests as indicators of presence and severity of coronary artery disease.

Authors:  N Goldschlager; A Selzer; K Cohn
Journal:  Ann Intern Med       Date:  1976-09       Impact factor: 25.391

9.  Stress testing with ST-segment depression at rest. An angiographic correlation.

Authors:  S Kansal; D Roitman; L T Sheffield
Journal:  Circulation       Date:  1976-10       Impact factor: 29.690

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.